Literature DB >> 23826512

Pharmacotherapies for Overeating and Obesity.

S Yarnell1, M Oscar-Berman, Nm Avena, K Blum, Ms Gold.   

Abstract

Obesity has become pandemic, and the annual cost in related illnesses and loss of productivity is already over $100 billion and rising. Research has shown that obesity can and does cause changes in behavior and in the brain itself that are very similar to changes caused by drugs of abuse. While food addiction is not the causal agent of all obesity, it is clear that many people no longer eat to survive, but instead survive to eat. This review considers the importance of the brain's reward system in food intake. The review also examines research developments and current treatments for obesity, including diet and exercise, psychotherapy, surgical interventions, and pharmacotherapies. Finally we discuss alterations in American society that are necessary for change to occur, and the diffculties therein.

Entities:  

Keywords:  Brain reward circuitry; Dopamine; Obesity; Pharmacotherapies; Reward Deficiency Syndrome (RDS); Social change

Year:  2013        PMID: 23826512      PMCID: PMC3697760          DOI: 10.4172/2157-7412.1000131

Source DB:  PubMed          Journal:  J Genet Syndr Gene Ther        ISSN: 2157-7412


  162 in total

1.  The process addictions and the new ASAM definition of addiction.

Authors:  David E Smith
Journal:  J Psychoactive Drugs       Date:  2012 Jan-Mar

Review 2.  The addictive brain: all roads lead to dopamine.

Authors:  Kenneth Blum; Amanda L C Chen; John Giordano; Joan Borsten; Thomas J H Chen; Mary Hauser; Thomas Simpatico; John Femino; Eric R Braverman; Debmalya Barh
Journal:  J Psychoactive Drugs       Date:  2012 Apr-Jun

3.  Activation of the sympathetic nervous system mediates hypophagic and anxiety-like effects of CB₁ receptor blockade.

Authors:  Luigi Bellocchio; Edgar Soria-Gómez; Carmelo Quarta; Mathilde Metna-Laurent; Pierre Cardinal; Elke Binder; Astrid Cannich; Anna Delamarre; Martin Häring; Mar Martín-Fontecha; David Vega; Thierry Leste-Lasserre; Dusan Bartsch; Krisztina Monory; Beat Lutz; Francis Chaouloff; Uberto Pagotto; Manuel Guzman; Daniela Cota; Giovanni Marsicano
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-04       Impact factor: 11.205

4.  Baclofen suppresses binge eating of pure fat but not a sugar-rich or sweet-fat diet.

Authors:  Laura A Berner; Miriam E Bocarsly; Bartley G Hoebel; Nicole M Avena
Journal:  Behav Pharmacol       Date:  2009-10       Impact factor: 2.293

5.  Induction of panic attack by stimulation of the ventromedial hypothalamus.

Authors:  W Bryan Wilent; Michael Y Oh; Cathrin M Buetefisch; Julian E Bailes; Diane Cantella; Cindy Angle; Donald M Whiting
Journal:  J Neurosurg       Date:  2010-06       Impact factor: 5.115

6.  Food reinforcement and impulsivity in overweight children and their parents.

Authors:  Leonard H Epstein; Kelly K Dearing; Jennifer L Temple; Meghan D Cavanaugh
Journal:  Eat Behav       Date:  2007-11-12

Review 7.  Acamprosate: recent findings and future research directions.

Authors:  Karl Mann; Falk Kiefer; Rainer Spanagel; John Littleton
Journal:  Alcohol Clin Exp Res       Date:  2008-07       Impact factor: 3.455

8.  Memantine in the treatment of binge eating disorder: an open-label, prospective trial.

Authors:  Brian P Brennan; Jacqueline L Roberts; Kate V Fogarty; Karina A Reynolds; Jeffrey M Jonas; James I Hudson
Journal:  Int J Eat Disord       Date:  2008-09       Impact factor: 4.861

Review 9.  Glutamatergic substrates of drug addiction and alcoholism.

Authors:  Justin T Gass; M Foster Olive
Journal:  Biochem Pharmacol       Date:  2007-06-30       Impact factor: 5.858

10.  Deep brain stimulation for treatment of obesity in rats.

Authors:  Sepehr Sani; Kirk Jobe; Adam Smith; Jeffrey H Kordower; Roy A E Bakay
Journal:  J Neurosurg       Date:  2007-10       Impact factor: 5.115

View more
  4 in total

Review 1.  Treatments for obesity in the context of nonalcoholic steatohepatitis and mental health.

Authors:  Aadi Sharma; Somaya Albhaisi; Arun J Sanyal
Journal:  Clin Liver Dis (Hoboken)       Date:  2022-07-16

2.  Fatty Acid Transport Proteins: Targeting FATP2 as a Gatekeeper Involved in the Transport of Exogenous Fatty Acids.

Authors:  Paul N Black; Constance Ahowesso; David Montefusco; Nipun Saini; Concetta C DiRusso
Journal:  Medchemcomm       Date:  2016-02-19       Impact factor: 3.597

Review 3.  Converging vulnerability factors for compulsive food and drug use.

Authors:  Katherine M Serafine; Laura E O'Dell; Eric P Zorrilla
Journal:  Neuropharmacology       Date:  2021-04-20       Impact factor: 5.273

Review 4.  Dopamine and glucose, obesity, and reward deficiency syndrome.

Authors:  Kenneth Blum; Panayotis K Thanos; Mark S Gold
Journal:  Front Psychol       Date:  2014-09-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.